ArticleFrontiers in immunology2025

Generation of novel human anti-OX-40 mAbs endowed with different biological properties as tools for cancer therapy.

Rosa Rapuano Lembo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.